BMY

Bristol-Myers Squibb Company (NYSE: BMY) Sec Form 8K

Bristol-Myers Squibb Company (NYSE: BMY) Q2 2025 Earnings Call dated Jul. 31, 2025 Corporate Participants: Charles E Triano — Senior…

Bristol-Myers Squibb Company (NYSE: BMY) Q3 2025 Earnings Call dated Oct. 30, 2025 Corporate Participants: Chuck Triano — Senior Vice…

Bristol Myers Squibb (NYSE: BMY) reported its third quarter 2025 earnings results today. Revenues increased 3% year-over-year to $12.2 billion.…

Bristol Myers Squibb (NYSE: BMY) reported its second quarter 2025 earnings results today. Total revenues inched up 1% year-over-year to…

Bristol Myers Squibb (NYSE: BMY) reported its third quarter 2024 earnings results today. Total revenues increased 8% year-over-year to $11.9…

Bristol Myers Squibb (NYSE: BMY) reported first quarter 2024 earnings results today. Total revenues increased 5% year-over-year to $11.9 billion.…

Bristol Myers Squibb (NYSE: BMY) reported fourth quarter 2023 earnings results today. Total revenues inched up 1% to $11.5 billion…

Biotechnology company Bristol Myers Squibb (NYSE: BMY) said its first-quarter adjusted earnings increased modestly, despite a decline in revenues. Net…

Bristol Myers Squibb (NYSE: BMY) reported revenues of $11.2 billion for the third quarter of 2022, down 3% from the…